In recent trading session, HCW Biologics Inc (NASDAQ:HCWB) saw 3.18 million shares changing hands at last check today with its beta currently measuring 0.71. Company’s recent per share price level of $4.51 trading at $0.29 or 6.95% at last check today assigns it a market valuation of $10.89M. That most recent trading price of HCWB’s stock is at a discount of -2135.03% from its 52-week high price of $100.80 and is indicating a premium of 11.31% from its 52-week low price of $4.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 73210.0 shares which gives us an average trading volume of 669.34K if we extend that period to 3-months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Upright in the green today for gaining 6.95%, in the last five days HCWB remained trading in the red while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $4.51 price level, adding 8.52% to its value on the day. HCW Biologics Inc’s shares saw a change of -85.66% in year-to-date performance and have moved -1.25% in past 5-day. HCW Biologics Inc (NASDAQ:HCWB) showed a performance of -43.59% in past 30-days. Number of shares sold short was 13034.0 shares which calculate 0.01 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -29.55% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 85.06% while estimates for its earnings growth in next 5 years are of 55.47%.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
Insiders are in possession of 29.80% of company’s total shares while institution are holding 1.47 percent of that, with stock having share float percentage of 2.09%. Investors also watch the number of corporate investors in a company very closely, which is 1.47% institutions for HCW Biologics Inc that are currently holding shares of the company. AVANTAX PLANNING PARTNERS, INC. is the top institutional holder at HCWB for having 0.28 million shares of worth $0.18 million. And as of 2024-06-30, it was holding 0.751 of the company’s outstanding shares.
The second largest institutional holder is HIGHTOWER ADVISORS, LLC, which was holding about 0.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.4857 of outstanding shares, having a total worth of $0.12 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 6.08 shares of worth $27963.0 or 0.42% of the total outstanding shares. The later fund manager was in possession of 3.47 shares on Apr 30, 2025 , making its stake of worth around $15952.0 in the company or a holder of 0.24% of company’s stock.
